Farletuzumab

• Description :

  Farletuzumab (MORAb-003) is a humanized monoclonal antibody with a high affinity for folate receptor-α (FRα), acting as a potent inhibitor of FRα and impeding the growth of cells that overexpress this receptor, making it useful for cancer research.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Molecular Formula :

  ——

• Notes :

  Research use only, not for human use.

• Receptor :

  Antifolate

• CAS Number :

  896723-44-7